http://rss.slashdot.org/~r/Slashdot/slashdot/~3/225761461/article.pl
eldavojohn writes "Doctors Without Borders is reporting that four
patents for tenofovir disoproxil fumarate, a key AIDS/HIV drug, have
been revoked on grounds of prior art. This is potentially good news for
India & Brazil who need this drug to be cheap; if the US action leads
to the patent being rejected in these countries, competition could
drastically lower prices. But the ruling bad news for Gilead Sciences.
The company has vowed to appeal. We discussed this drug before."
Read more of this story at Slashdot.
--
Nenhum comentário:
Postar um comentário